218 Roper Mountain Road Ext., Greenville, SC 29615

Phone (864) 509-6111    Fax (864) 509-6112


1. FT Thandroyen, RE Matisonn, EK Weir: Severe aortic incompetence caused by systemic lupus erythe-matosus. S Afr Med J 4:166-168, 1978.
2. AC Asmal, WP Leary, FT Thandroyen, J Botha, S Wattrus: A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects. Br J Clin Pharmacol 7:531-533, 1979.
3. LH Opie, FT Thandroyen, CA Muller, OL Bricknell: Adrenaline-induced oxygen wastage and enzyme release from working rat heart. Effect of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation. J Molec Cell Cardiol 11:10873-1904, 1979.
4. FT Thandroyen, AC Asmal, WP Leary, AS Mitha: Comparative study of plasma lipids, carbohydrate in-tolerance and coronary angiography in three racial groups. S Afr Med J 57:533-536, 1980.
5. FT Thandroyen, AC Asmal, WP Leary, AS Mitha: Severe calcification of glutaraldehyde preserved por-cine xenografts in children. Am J Cardiol 45:690-696, 1980.
6. FT Thandroyen, AC Asmal, CI Bhagat, B Dayal: Automatic neuropathy in non-insulin dependent diabe-tes mellitus in the young. S Afr Med J 58:55-57, 1980.
7. AC Asmal, WP Leary, FT Thandroyen: Diabetic heart disease. S Afr Med J 57:788-790, 1980.
8. FT Thandroyen, AC Asmal, TG Armstrong: Varicella myocarditis producing congestive cardiomyopathy. Postgrad Med J 57:199-201, 1981.
9. FT Thandroyen, RE Matisonn: Penetrating thoracic trauma producing cardiac shunts. J Thoracic Cardiovasc Surg 81:569-573, 1981.
10. AC Asmal, I Jialal, WP Leary, P Makhoba, MAK Omar, NL Pillay, FT Thandroyen: Non-insulin depend-ent diabetes mellitus in Blacks and Indians. S Afr Med J 60:1981.
11. AC Asmal, B Dayal, I Jialal, WP Leary, MAK Omar, NL Pillay, FT Thandroyen: Non-insulin dependent diabetes mellitus in Blacks and Indians. S Afr Med J 60:1981.
12. FT Thandroyen, LM Higginson, LH Opie: The interaction between cAMP and calcium and vulnerability to ventricular fibrillation. Bas Res in Cardiol 76:449-451, 1981.
13. FT Thandroyen: Protective action of calcium channel antagonist agents against ventricular fibrillation in isolated perfused rat heart. J Molec Cell Cardiol 14:21-32, 1982.
14. CW Hamm, FT Thandroyen, LH Opie: Protective effects on isolated hearts with developing myocardial infarction: slow channel blockage by diltiazem versus beta adrenoceptor antagonism by metoprolol. Am J Cardiol 50:857-863, 1982.
15. LH Opie, FT Thandroyen, CW Hamm, CA Muller, EA Lloyd: Calcium antagonists and the acutely is-chemic heart. Europ Heart J 4:93-100. (Supp C), 1983.
16. LH Opie, FT Thandroyen, MW Worthington, LM Higginson, LH Opie: The effect of alpha and beta adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart. J Am Coll Cardiol 1:1056-1066, 1983. CURRICULUM VITAE Francis T. Thandroyen Page 9
17. FT Thandroyen, LH Opie: Contrasting effects of beta-adrenoceptor antagonists and of calcium antagonists on ventricular fibrillation and enzyme release associated with experimental myocardial infarction. Fed Proc 42:2465-2469, 1983.
18. FT Thandroyen: Ventricular arrhythmogenesis during acute myocardial ischemia in isolated perfused rat heart. M.D. Thesis 1984.
19. FT Thandroyen, RE Samson, GR Keeton: Hemorrhagic right pleural effusion due to acute on chronic pancreatitis. S Afr Med J 65:933-934, 1984.
20. FT Thandroyen, P Klemp, RE Samson, GM Mody, PM Swift, GR Keeton: SLE in three Black South African males. S Afr Med J 65, 1984.
21. LH Opie, FT Thandroyen: Molecular mechanisms underlying role of calcium ions in ventricular arrhythmogenesis during acute myocardial ischemia. Ann New York Acad SC 427:127-139, 1984.
22. AM Wheatley, FT Thandroyen, LH Opie: Catecholamine induced myocardial damage: Adrenaline versus adrenochrome. J Molec Cell Cardiol 17:349-359, 1985.
23. FT Thandroyen, LM Higginson, LH Opie: Influence of verapamil and its isomers on vulnerability to ventricular fibrillation during acute myocardial ischemia and adrenergic stimulation. J Molec Cell Cardiol 18:645-649, 1986.
24. FT Thandroyen, N Flint, MW Worthington, LH Opie: Arrhythmogenic action of alpha adrenoceptor stimulation in the isolated perfused rat heart. J Molec Cell Cardiol 19:841-851, 1987.
25. LH Opie, WA Coetzee, S Denis, FT Thandroyen: role of calcium ions in ventricular arrhythmogenesis. Ann New York Acad SC 522:464-477, 1988.
26. FT Thandroyen, J McCarthy, LH Opie: Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in isolated rat heart. Circ Res 62:306-314, 1988.
27. CA Muller, CW Hamm, CA Pineda, D Gihwala, LH Opie, FT Thandroyen: Influence of verapamil and tiapamil on ventricular fibrillation and ventricular function. Circulation 78:227-232, 1988.
28.CA Muller, LH Opie, M Peisach, CA Pineda, FT Thandroyen: Critical role of dose in protection by propranolol against ventricular fibrillation in a pig model of acute myocardial ischemia. J Cardiovasc Pharm 13:192-197, 1989.
29. FT Thandroyen, KH Muntz, T Rosenbaum, B Ziman, JT Willerson, LM Buja: Characterization of beta adrenergic receptor-adenylate cyclase system during hypoxia in isolated neonatal ventricular myocytes. Am J Physiol 256:H1209-H1217, 1989.
30. WA Shapiro, KA Nahara, JB Kostis, FT Thandroyen, LR Zohman: Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am J Cardiol 64:186-190, 1989.
31. FT Thandroyen, KH Muntz, LM Buja, JT Willerson: Alterations in beta adrenergic receptors, adenylate cyclase, and cyclic AMP during acute myocardial ischemia. Circulation 82: (Suppl II):II-30-II-37, 1990.
32. CA Muller, MG Worthington, FT Thandroyen: Antiarrhythmic and metabolic profile of alpha adrenoceptor antagonism. J Cardiovasc Pharm 15:408-413, 1990.
33. AL Taylor, R Winter, FT Thandroyen, S Murphree, LM Buja, R Eckels, M Kremers: Potentiation of reperfusion ventricular fibrillation by left ventricular hypertrophy. Circ Res 67:501-509, 1990.
34. FT Thandroyen, AC Morris, B Ziman, L Pai, HK Hagler, JT Willerson, LM Buja: Intracellular calcium transients and arrhythmias in isolated heart cells. Circ Res 69:810-819, 1991.
35. FT Thandroyen, D Bellotto, A Katayama, HK Hagler, JT Miller, JT Willerson, LM Buja: Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes. Mechanisms of calcium loading during hypoxia and reoxygenation in isolated heart cells. Circ Res 1992:72;106-119.
36. FT Thandroyen, S Vignale, M Kapusta, G Li: Progressive peripheral edema and jugular venous distention within six weeks of bypass grafting and automatic cardiac defibrillator implantation. Circulation 1994:89;2434-2441.
37.FT Thandroyen, M Phillips, D d’Souza, LM Buja: A 24 year old man with extensive lower limb edema and acute arterial occlusion. Circulation 1994:90;2115-2123.
38. P Lozano, E Al-Mousa, CF Wei, FT Thandroyen: Intraaortic thrombus as a cause of embolic arterial disease. Circulation 1996: 93; 1471.
39. SA Austin, FJ Vriesendorp, FT Thandroyen, JT Hecht, OT Jones, DR Johns: Expanding the phenotype of the 8344 tRNAlysine mitochondrial DNA mutation. Neurology 1998, 1447-1450.
40. S Basaria, AE Denktas, M Ghani, FT Thandroyen: VSD patch causing right ventricular inflow tract obstruction. Circulation 1999, 100:12-13

Publications: Book Chapters
1.AC Asmal, FT Thandroyen, WP Leary, I Jialal, C Bentley-Phillips, N Pillay: An evaluation of the efficacy and safety of glicazide compared to chlorpropamide. Proceedings of the Royal Society of Medicine, International Congress and Symposium Series. Academic Press Inc. (London) 113-122, 1981.
2.LH Opie, FT Thandroyen, WC Hamm: Beta-Blockade: metabolic and antiarrhythmic effects in myocardial infarction. Advanced in Beta-Blocker Therapy 11. Proceedings of the Second International Symposium. Excerpta Medica 40-64, 1982.
3. LH Opie, FT Thandroyen, CA Muller, PS Daries: Catecholamines, cyclic AMP and arrhythmias: role for Ca and Ca antagonist agents. Elsevier/North Holland Biochemical Press Eds. Reimersma and Oliver 13:201-219, 1982.
4. FT Thandroyen, LM Higginson, LH Opie: Cholinergic modulation of enhanced vulnerability to ventricular fibrillation evoked by adrenergic stimulation. Advances in Myocardiology, Baltimore Press, Eds. Chazov V, Dhalla NS. 3:199-204, 1982.
5. FT Thandroyen, MW Worthington, LH Opie: Combined alpha-beta adrenergic antagonists agents prevent ventricular fibrillation. Advances in Heart Metabolism. Eds. Calderra and Harris 159-163, 1982.
6. LH Opie, FT Thandroyen, CA Muller, CW Hamm: Calcium channel antagonist agents as antiarrhythmic agents: Contrasting properties of verapamil, nifedipine and diltiazem. Ed. Opie LH. Raven Press, New York, 303-311, 1984.
7. FT Thandroyen, S Saman, LH Opie: Serotonin and the Heart: Pharmacologic evaluation with serotonin antagonist, Ketanserin. Serotonin and the Cardiovascular System. Ed. Vanhoutte PM. Raven Press, New York, 87-03, 1985.
8. N Flint, MW Worthington, LH Opie, FT Thandroyen: Alpha adrenergic mediated positive inotrophy, possible role of transsarcolemmal Ca influx and sarcoplasmic reticulum Ca release. Muscles and Membrane, Eds. Berman MC, Gevers W, Opie LH. 1986.
9. FT Thandroyen, LH Opie: Multiple sites of modulation of calcium ion movement in cardiac muscle: Implications for early ischemic ventricular fibrillation. Muscles and Membrane, Eds. Berman MC, Gevers W, Opie LH. 1986.
10. FT Thandroyen: Echocardiography in coronary artery disease. Cardiovascular Medicine. Eds. Willerson JT, Cohn JN. Churchill Livingstone. 1994:464-475.
11. WR Wilson, FT Thandroyen: Infective Endocarditis. Cardiovascular Medicine. Eds. Willerson JT, Cohn JN. Churchill Livingstone. 1994:240-256.
12. FT Thandroyen, M Adams: Echocardiography in cardiomyopathy. Cardiovascular Medicine. Eds. Willerson JT, Cohn JN. Churchill Livingstone. 1994:934-941.